|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02252 MEDBOT-B
Nominal 
8.170 -0.980 (-10.710%) | 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Turnover | 104,592 | 384.155% | 21,603 | 2,150 | 0 | 0 |
| Cost of Sales | (89,898) | 497.686% | (15,041) | (1,231) | -- | -- |
| Gross Profit | 14,694 | 123.926% | 6,562 | 919 | -- | -- |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | (3,250) | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (29,803) | -24.844% | (39,655) | (27,377) | (1,675) | 0 | |
| Profit / (Loss) before Taxation | (1,023,530) | -10.709% | (1,146,284) | (584,507) | (209,290) | (69,801) | |
| Taxation | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 11,356 | 75.301% | 6,478 | 1,586 | 416 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (1,012,174) | -11.198% | (1,139,806) | (582,921) | (208,874) | (69,801) | |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 9,716 | -- | (15,287) | (16,638) | 41,099 | (535) |
| Depreciation & Amortisation | 111,759 | 10.976% | 100,706 | 35,373 | 4,457 | 3,140 |
| Directors' Emoluments | 45,868 | -1.329% | 46,486 | 36,843 | 5,718 | 1,626 |
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| EPS (cts) | -106.000 | -10.924% | -119.000 | -63.000 | -27.000 | -- |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | (0.592) | -- | (0.937) | (0.588) | (0.136) | -- |
| NBV per share ($) | 0.542 | -- | 1.479 | 2.497 | -- | -- |
| Remarks: | Real time quote last updated: 22/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -277,161,000 |
| %Change | -48.580% |
| EPS / (LPS) | RMB -0.290 |
| NBV Per Share (¥) | RMB 0.287 |